STXS Stereotaxis Inc

Price (delayed)

$1.9

Market cap

$157.02M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.26

Enterprise value

$144.16M

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic ...

Highlights
Stereotaxis's debt has decreased by 7% YoY
The net income has grown by 4.1% from the previous quarter
STXS's equity is down by 39% year-on-year and by 11% since the previous quarter
STXS's quick ratio is down by 22% YoY and by 6% QoQ

Key stats

What are the main financial stats of STXS
Market
Shares outstanding
82.64M
Market cap
$157.02M
Enterprise value
$144.16M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.71
Price to sales (P/S)
5.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.32
Earnings
Revenue
$27.1M
EBIT
-$19.87M
EBITDA
-$19.27M
Free cash flow
-$8.7M
Per share
EPS
-$0.26
Free cash flow per share
-$0.1
Book value per share
$0.18
Revenue per share
$0.32
TBVPS
$0.47
Balance sheet
Total assets
$39.45M
Total liabilities
$19.42M
Debt
$5.39M
Equity
$14.57M
Working capital
$18.36M
Liquidity
Debt to equity
0.37
Current ratio
2.43
Quick ratio
1.73
Net debt/EBITDA
0.67
Margins
EBITDA margin
-71.1%
Gross margin
55.2%
Net margin
-73.3%
Operating margin
-77.4%
Efficiency
Return on assets
-48.7%
Return on equity
-119.5%
Return on invested capital
-139.2%
Return on capital employed
-74.7%
Return on sales
-73.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STXS stock price

How has the Stereotaxis stock price performed over time
Intraday
-1.04%
1 week
7.95%
1 month
-2.06%
1 year
27.52%
YTD
8.57%
QTD
4.4%

Financial performance

How have Stereotaxis's revenue and profit performed over time
Revenue
$27.1M
Gross profit
$14.95M
Operating income
-$20.97M
Net income
-$19.87M
Gross margin
55.2%
Net margin
-73.3%
Stereotaxis's gross profit has decreased by 14% YoY
STXS's gross margin is down by 12% YoY
STXS's operating margin is down by 5% YoY but it is up by 5% from the previous quarter
Stereotaxis's net margin has increased by 5% from the previous quarter but it has decreased by 3.7% YoY

Growth

What is Stereotaxis's growth rate over time

Valuation

What is Stereotaxis stock price valuation
P/E
N/A
P/B
10.71
P/S
5.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.32
The EPS has grown by 3.7% from the previous quarter and by 3.7% YoY
STXS's equity is down by 39% year-on-year and by 11% since the previous quarter
STXS's P/B is 19% above its last 4 quarters average of 9.0 and 9% above its 5-year quarterly average of 9.8
The stock's price to sales (P/S) is 38% less than its 5-year quarterly average of 9.4 but 6% more than its last 4 quarters average of 5.5
STXS's revenue is down by 2% YoY

Efficiency

How efficient is Stereotaxis business performance
STXS's return on invested capital has dropped by 75% year-on-year and by 32% since the previous quarter
Stereotaxis's return on equity has shrunk by 54% YoY and by 9% QoQ
Stereotaxis's ROA has decreased by 26% YoY and by 2.3% from the previous quarter
The ROS has grown by 5% from the previous quarter but it has contracted by 3.7% YoY

Dividends

What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STXS.

Financial health

How did Stereotaxis financials performed over time
The company's total assets is 103% higher than its total liabilities
STXS's quick ratio is down by 22% YoY and by 6% QoQ
The company's total assets fell by 22% YoY and by 6% QoQ
Stereotaxis's debt is 63% less than its equity
STXS's debt to equity has soared by 54% year-on-year and by 9% since the previous quarter
STXS's equity is down by 39% year-on-year and by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.